Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans

NCT00625014 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT00625014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00625014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans
Lead sponsor
Leiden University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2005
Completion date
July 31, 2005
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, insulin resistance